PUBLISHER: The Business Research Company | PRODUCT CODE: 1829924
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829924
Urethral stricture treatment devices are medical tools designed to address urethral stricture, a condition where the urethra becomes narrowed, often causing urinary retention and difficulty with urination. These devices work to widen or bypass the constricted area of the urethra, restoring normal urine flow, and are used in both surgical and non-surgical treatment options.
The primary products in urethral stricture treatment devices include urethral dilators, urethral stents, urethral balloon dilation catheters, and urinary catheters. Urethral dilators are instruments used to gradually widen or stretch a narrowed urethra, facilitating easier urine flow. They are commonly used in procedures to treat urethral strictures by progressively increasing the diameter of the urethra. The strictures may be located in either the anterior or posterior sections, and the devices are typically used by end users such as hospitals, specialty clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The urethral stricture treatment devices market research report is one of a series of new reports from The Business Research Company that provides urethral stricture treatment devices market statistics, including urethral stricture treatment devices industry global market size, regional shares, competitors with a urethral stricture treatment devices market share, detailed urethral stricture treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the urethral stricture treatment devices industry. This urethral stricture treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The urethral stricture treatment devices market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to a rise in the prevalence of urethral strictures, increased adoption of minimally invasive treatments, increased awareness about urological disorders, a rise in healthcare expenditure in developed regions, and improved diagnostic capabilities.
The urethral stricture treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing demand for outpatient procedures, growing focus on patient-centered care, expanding healthcare infrastructure in emerging markets, rising cases of trauma-related strictures, and awareness campaigns by healthcare organizations. Major trends in the forecast period include a shift toward minimally invasive surgeries, integration of AI in diagnostic tools, technological advancements in surgical devices, advancements in medical imaging techniques, and a focus on personalized treatment solutions.
The forecast of 7.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for balloon dilation catheters and biodegradable urethral stents, sourced from key regions such as Italy and India, could lead to higher costs for urological procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder is expected to drive the growth of the urethral stricture treatment devices market. BPH is a common condition among older men, characterized by an enlarged prostate that can obstruct urinary flow and heighten the risk of urethral strictures. The rise in BPH cases is largely due to aging, with a higher frequency observed in men over 50, as well as factors such as lifestyle, hormonal changes, and chronic conditions. Urethral stricture treatment devices are often used in managing urological issues such as BPH, where complications such as post-surgical effects or prolonged catheterization may cause urethral narrowing. This may require the use of dilators, stents, or urethrotomy tools to restore proper urinary function. For example, a report from the Royal Pharmaceutical Society in September 2023 stated that approximately 3 million individuals in the UK are affected by BPH, with 50% of men aged 60-70 years and 90% of men over 80 years experiencing the condition. Therefore, the increasing prevalence of BPH and neurogenic bladder is expected to contribute to the growth of the urethral stricture treatment devices market.
Leading companies in the urethral stricture treatment devices market are pursuing strategic partnerships to improve technology integration and broaden their market presence. A strategic partnership involves two or more organizations working together, sharing resources and expertise to achieve mutual objectives. For example, in April 2024, Laborie Medical Technologies Corp., a US-based company specializing in diagnostic and therapeutic medical technologies, formed a partnership with the NHS Specialized Services Device Programme (SSDP). This collaboration enabled the inclusion of Laborie's Optilume Urethral Drug-Coated Balloon (DCB) in the program, ensuring reimbursement for NHS hospitals in England and improving patient access to the device. Optilume combines balloon dilation with anti-proliferative drug delivery, offering a solution to reduce the recurrence of urethral strictures. This innovative, minimally invasive technology provides an alternative to traditional surgery or repeated treatments, addressing a significant need within the field of urology.
In October 2023, Laborie Medical Technologies Corp., a US-based company specializing in diagnostic and therapeutic medical technologies, acquired Urotronic Inc. for an undisclosed sum. This acquisition allows Laborie to incorporate Urotronic's Optilume drug-coated balloon technology into its range of interventional urology solutions. The technology is designed to treat conditions such as urethral strictures and benign prostatic hyperplasia (BPH). Urotronic Inc. is a US-based medical device company focused on developing urethral stricture treatment devices and other urological treatment technologies.
Major players in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, and Zhejiang ChuangXiang Medical Technology Co. Ltd.
North America was the largest region in the urethral stricture treatment devices market in 2024. The regions covered in urethral stricture treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the urethral stricture treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The urethral stricture treatment devices market consists of sales of laser urethrotomy devices, biodegradable stents, lubricants, urethral calibration sets, and bougies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urethral Stricture Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urethral stricture treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for urethral stricture treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urethral stricture treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.